Medical Affairs Share this page The growing complexity of healthcare data obtained from multiple sources has led to an increasingly important role for medical affairs teams in providing essential scientific and medical context. Our expertise lies in offering full support on all medical affairs activities throughout the product life cycle, from evidence generation and strategy planning to clear communication of medical content tailored to physicians, patients, regulators, payers and policymakers. Our key service offerings include: situation and evidence gap analyses multichannel strategy and platform development publications strategy, planning and delivery educational content development and delivery external expert identification and management internal training and communications educational content dissemination medical information content development Enquiries Get in touch © 2021 Oxford PharmaGenesis Terms Privacy and Security COVID-19 Statement GPG report We'll assume you're ok with this, but you can opt-out if you wish.

Real-world Evidence Share this page Pharmaceutical companies are investing heavily in expertise and systems for generating and using real-world evidence (RWE), to demonstrate the value of their medicines in real-world populations throughout product life cycles. Our experience spans the full range of real-world data, from registries and health system database studies to health monitoring devices and apps. We are proud to support our clients’ ambitions by communicating innovation and best practice across their internal networks and with the healthcare community. Our key service offerings include: RWE planning, generation, communications strategy and coordination SURETM real-world data source analysis process and governance optimization and communication change management and training programmes Enquiries Get in touch © 2021 Oxford PharmaGenesis Terms Privacy and Security COVID-19 Statement GPG report We'll assume you're ok with this, but you can opt-out if you wish.

Value Demonstration Share this page Successful patient access requires an integrated approach to demonstrating product value, using robust evidence and compelling communications to inform healthcare decision-making. We specialize in delivering decision-shaping value communications and performing high-calibre research to facilitate access throughout the product life cycle. Our expertise at matching health economic and clinical knowledge to commercial objectives ensures the right messages resonate with the right audience at the right time. Our key service offerings include: health economics and outcomes research publications and communications systematic and targeted literature reviews and meta-analyses value proposition and value story development and testing capability building and learning and development programmes value dossiers, health technology assessment and reimbursement submissions Enquiries Get in touch © 2021 Oxford PharmaGenesis Terms Privacy and Security COVID-19 Statement GPG report We'll assume you're ok with this, but you can opt-out if you wish. Cookie SettingsACCEPT ALL